LIPUM

Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic inflammatory diseases. Lipum has a biological anti-inflammatory drug candidate developed against Rheumatoid Arthritis (RA) – an autoimmune disease characterized by chronic inflammation of the joints. It often causes disability and lowers the quality of life for millions. Lipum also addresses the treatment of Juvenile Idiopathic Arthritis (JIA) that is a rare disease affecting children. A nove... l biological drug for this disease may be considered for an orphan drug designation. Treatment of other chronic inflammatory conditions is also explored. Related diseases are such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis. Lipum's biological anti-inflammatory drug candidate provides a novel mechanism of action. Therefore, it is assumed to have less adverse effects than current treatments in use.

#People #Financial #Event #Website #More

LIPUM

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

2010-01-01

Address:

Umeå, Vasterbottens Lan, Sweden

Country:

Sweden

Website Url:

http://www.lipum.se

Total Employee:

Status:

Active

Contact:

+46 90 340 34 30

Email Addresses:

[email protected]

Total Funding:

351.19 K USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box